SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is experiencing a volatile trend as community members fiercely debate the onset of a "meme coin season," with strong conviction buys contrasting sharply against widespread accusations of it being a "scam" or "shit coin."

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending strongly, fueled by its deepened integration into the AI sector through initiatives like the NVIDIA Inception Program, and the expanding utility of its NEAR Intents for seamless cross-chain transactions. Community sentiment points to its growing adoption and role as a foundational interoperability layer, with many actively discussing its potential for future appreciation as an undervalued asset in the evolving crypto market.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending following the full commercial availability of its year-long Eversense 365 CGM integrated with Sequel MedTech's twiist AID system in the U.S., alongside recent CE Mark approval for Europe. The community is actively debating if this and favorable revenue trends will finally drive widespread adoption of its superior technology, overcoming past concerns about management and market execution.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as its new drug Bysanti, a New Chemical Entity with patent protection until 2044 for schizophrenia and bipolar I disorder, received FDA approval, sparking community discussions about a significant valuation re-rating, analyst upgrades, and potential buyout offers from Big Pharma seeking to offset upcoming patent cliffs and leverage Vanda's pipeline, including its GLP-1 nausea candidate.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies Inc. is a focal point of market discussion following its graduation from Shell's GameChanger program and successful $20 million public offering to fund its demonstration plant. Investors are keenly debating the long-term, multi-bagger potential of its plastic recycling technology against ongoing concerns about commercial proof of concept and revenue generation.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as recent reports on its CEO's private investments ignite community debate and amplify concerns over ongoing regulatory pressure, with investors sharply divided on whether legislative threats or intrinsic value will drive its next move.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending with high community interest, focusing on its 'move-to-earn' utility where users earn crypto through physical activity. Despite its current low valuation, many investors express optimism about its long-term potential, while technical analysis suggests a potential buy signal.

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication; Energy, Utilities, Resources, and Services; Manufacturing, Hi-Tech, Life Sciences, and All Other. The company was founded by Dinesh Krishnan Swamy, Senapathy Gopalakrishnan, Narayana Ramarao Nagavara Murthy, Raghavan N. S., Ashok Arora, Nandan M. Nilekani, and S. D. Shibulal on July 2, 1981 and is headquartered in Bangalore, India.

Infosys Ltd - ADR

Infosys Technologies Limited

Infosys is a major talking point as its numerous AI collaborations and platform advancements, including a recent partnership with Anthropic, are actively debated against widespread market concerns that AI automation could simultaneously disrupt the traditional IT consulting business model it relies on.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is trending due to a strategic partnership with TenX Protocols and a significant token acquisition, fueling community speculation about a meme coin rally despite lingering skepticism about its long-term utility.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as its FDA-approved drug, Yartemlea, begins commercial shipments and patient treatments for a rare, life-threatening condition. Despite significant community belief in its market potential and upcoming catalysts like potential European approval and Novo Nordisk milestone payments, many are frustrated by perceived market manipulation and high short interest suppressing its share price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?

IRWD has the edge over BHC with high Linzess demand and upbeat 2026 revenue outlook offsetting pipeline and pricing risks.

BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth

Bausch stock slips as Q4 EPS misses despite 9% revenue growth, strong Salix and Bausch + Lomb gains, and an upbeat 2026 sales outlook.

Bausch Health Cos (NYSE:BHC) Shares Gap Down - Time to Sell?

Bausch Health Cos (NYSE:BHC) Shares Gap Down - Here's What Happened...

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN (minocycline HCl) Microspheres

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN (minocycline HCl) Microspheres Bausch Health's OraPharma Celebrates 25 Years of ARESTIN (minocycline HCl) Microspheres PR Newswire LAVAL, QC...

Bausch Health Cos Q4 Earnings Call Highlights

Bausch Health Cos (NYSE:BHC) executives said the company finished 2025 with its eleventh consecutive quarter of growth in revenue and adjusted EBITDA, as management highlighted broad-based commercial...

Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings

The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Bausch Health (BHC) Q4 Earnings Lag Estimates

Bausch (BHC) delivered earnings and revenue surprises of -10.50% and +3.38%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Bausch Health Cos (NYSE:BHC) Releases Earnings Results, Misses Expectations By $0.14 EPS

Bausch Health Cos (NYSE:BHC - Get Free Report) released its earnings results on Wednesday. The company reported $1.08 earnings per share for the quarter, missing analysts' consensus estimates of...

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS PR Newswire LAVAL, QC, Feb. 18, 2026 Fourth Quarter Consolidated...

Bausch Health Companies Q4 25 Earnings Conference Call 5:00 PM ET

(RTTNews) - Bausch Health Companies Inc (BHC.TO) will host a conference call at 5:00 PM ET on February 18, 2026, to discuss Q4 25 earnings results...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.71	--	--	N/A
Q4 '25	$1.20	$1.08	-10.58%	MISSED
Q3 '25	$1.06	$1.16	9.53%	BEAT
Q2 '25	$0.94	$1.05	11.37%	BEAT
Q1 '25	$0.83	$0.61	-26.88%	MISSED

BHC
Bausch Health Companies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest BHC News

BHCBausch Health Companies Inc